{"gene":"ITGAE","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":2000,"finding":"The αE(CD103)β7 integrin binds E-cadherin on epithelial cells, mediating T cell adhesion to epithelial surfaces. CCL25 (via CCR9) induces transient, dose-dependent and pertussis toxin-sensitive CD103-mediated adhesion of CD8+ intraepithelial lymphocytes to E-cadherin.","method":"Adhesion assay using murine E-cadherin-Fc fusion protein; pertussis toxin inhibition","journal":"Current opinion in cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional adhesion assay with pharmacological inhibition, single lab","pmids":["10978890"],"is_preprint":false},{"year":2002,"finding":"CD103 expression on CD8+ T cells is required for intragraft migration into epithelial compartments and destruction of pancreatic islet allografts; CD103-/- CD8 cells trafficked normally to the graft site but failed to infiltrate the islet itself, demonstrating CD103's role in promoting CD8 effector infiltration of epithelial layers.","method":"Genetic knockout (CD103-/- mice), adoptive transfer of wild-type vs CD103-/- CD8 T cells, in vivo islet allograft transplantation model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal transfer experiments in KO and WT mice with clear phenotypic readout, well-controlled epistasis","pmids":["12370250"],"is_preprint":false},{"year":2004,"finding":"CCR9 signaling via its ligand CCL25 promotes induction of CD103 on CD8+ T cells upon entry into the small intestinal epithelium; CCR9-/- CD8 T cells showed significant delay in CD103 induction at this site.","method":"CCR9-/- mouse model, adoptive transfer, flow cytometry of intestinal intraepithelial lymphocytes","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined cellular phenotype, single lab","pmids":["15368288"],"is_preprint":false},{"year":2005,"finding":"The transcription factor Runx3 is necessary for CD103 (integrin αE) induction during development of CD8 single-positive thymocytes; Runx3 deletion reduces CD103 expression, and Runx3 overexpression upregulates CD103 on CD8 SP T cells and a subpopulation of CD4 SP T cells.","method":"Runx3 knockout and transgenic overexpression mouse models, flow cytometry of thymic T cell subsets","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — both loss-of-function and gain-of-function genetic experiments with clear phenotypic readout, replicated across multiple mouse models in single study","pmids":["16034110"],"is_preprint":false},{"year":2005,"finding":"CD103 expression on dendritic cells (not T cells) is required for T regulatory cell-mediated control of colitis; CD103+ DCs (but not CD103- DCs) promote expression of gut-homing receptor CCR9 on T cells, while CD103- DCs promote IFN-γ-producing T cell differentiation.","method":"CD103-/- mice, T cell transfer colitis model, adoptive transfer of CD4+CD25+ Tregs, in vitro DC-T cell co-culture assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined functional readout, in vivo and in vitro orthogonal approaches, reciprocal transfer experiments","pmids":["16216886"],"is_preprint":false},{"year":2009,"finding":"CD103+ DCs in nonlymphoid tissues are exclusively derived from pre-DCs under control of Flt3 ligand, Id2, and IRF8, sharing the same precursor and differentiation program as lymphoid organ CD8+ DCs; in contrast, lamina propria CD103+CD11b+ DCs develop independently of Id2 and IRF8.","method":"Flt3-/-, Id2-/-, and IRF8-/- mouse models, bone marrow reconstitution, flow cytometry of DC subsets across tissues","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic KO models with defined developmental phenotypes across tissues","pmids":["20008528"],"is_preprint":false},{"year":2009,"finding":"CD103 expression on tumor-infiltrating CD8+ T cells is triggered by co-engagement of TCR and TGF-β1 receptor in the tumor microenvironment; once induced, αEβ7 integrin interaction with E-cadherin on tumor cells recruits CCR5 to the immunological synapse, inhibiting T cell sensitivity to CCL5 chemotactic gradient and promoting T cell retention at the tumor site.","method":"Adoptive transfer in NOD/SCID mice, in vivo TCR + TGF-β1 co-stimulation, immunological synapse analysis, CCR5 recruitment assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo adoptive transfer plus mechanistic synapse analysis, single lab, multiple methods","pmids":["19638592"],"is_preprint":false},{"year":2010,"finding":"The transcription factor Batf3 is required for development of CD103+CD11b- DCs in lung, intestine, mesenteric lymph nodes, dermis, and skin-draining lymph nodes; Batf3-/- mice lack these cells and show reduced CD8 T cell priming after pulmonary viral infection, establishing a developmental relationship between lymphoid organ CD8α+ DCs and nonlymphoid CD103+ DCs via shared dependence on Batf3 and Irf8.","method":"Batf3-/- and Irf8-/- mouse models, flow cytometry across tissues, viral infection challenge, gene expression profiling","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple KO models, multiple tissues examined, functional immune readout, orthogonal gene expression data","pmids":["20351058"],"is_preprint":false},{"year":2011,"finding":"CD103+ pulmonary DCs selectively acquire and transport apoptotic cell-associated antigen to draining lymph nodes and cross-present it to CD8 T cells; this selective role requires TLR3 expression on CD103+ DCs, and TLR3 ligation enhances CTL responses to apoptotic cell-associated antigen.","method":"Batf3-/- mice lacking CD103+ DCs, in vivo apoptotic cell transport assays, TLR3 ligation experiments, CTL response measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO confirmation, functional antigen transport and cross-presentation assays, TLR3 mechanistic link","pmids":["21859845"],"is_preprint":false},{"year":2013,"finding":"CD103+CD8+ tissue-resident memory T cells in skin develop from KLRG1- epithelium-infiltrating precursor cells; their formation requires a combination of epithelial entry plus local IL-15 and TGF-β signaling, and these cells acquire a unique transcriptional profile distinct from circulating memory cells.","method":"Mouse skin infection model, parabiosis, IL-15 and TGF-β blocking experiments, transcriptional profiling, flow cytometry","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — parabiosis, cytokine blocking, transcriptional profiling, multiple orthogonal methods in single study","pmids":["24162776"],"is_preprint":false},{"year":2014,"finding":"The transcription factors Smad2/3 and NFAT-1 are critical regulators of CD103 induction in CD8 T cells; TGF-β1 and TCR co-engagement cooperatively drive CD103 (ITGAE gene) expression through promoter and enhancer elements of the human ITGAE gene.","method":"Human CTL clone system, Smad2/3 and NFAT-1 transcription factor analysis, ITGAE promoter/enhancer mapping, TGF-β1 and TCR stimulation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter/enhancer mapping with transcription factor identification, in vitro mechanistic dissection, single lab with multiple methods","pmids":["24477908"],"is_preprint":false},{"year":2014,"finding":"CD103+ DC development in vitro requires prolonged culture with both FLT3L and GM-CSF acting on DC precursors and differentiating CD103+ DCs; these cells develop in a Batf3- and Irf8-dependent fashion, cross-present cell-associated antigens, respond to TLR3 stimulation, and upregulate CCR7 upon maturation enabling lymph node migration.","method":"Bone marrow culture differentiation, Batf3-/- and Irf8-/- genetic validation, antigen cross-presentation assays, TLR3 stimulation, CCR7 expression and migration assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic validation in KO mice plus multiple functional assays in single study","pmids":["25100743"],"is_preprint":false},{"year":2015,"finding":"CD103-/- mice develop exacerbated lung inflammation with increased eosinophilic infiltration and defective resolution phase in asthma models, demonstrating CD103 plays a role in controlling airway inflammation severity.","method":"CD103-/- mice in ovalbumin and house dust mite asthma models, bronchoalveolar lavage analysis, histology, flow cytometry","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined phenotypic readout in two independent mouse models, single lab","pmids":["25681437"],"is_preprint":false},{"year":2016,"finding":"The transcription factor NR4A3 is cell-intrinsically required for CD103+ DC migration to lymph nodes by regulating surface CCR7 expression on CD103+ DCs (but not T cells); NR4A3 maintains FOXO1 protein levels via an AKT-dependent mechanism, which in turn drives CCR7 expression; NR4A3 is also required for homeostatic mitochondrial function in CD103+ DCs.","method":"Nr4a3-/- mice, mixed bone marrow chimeras (cell-intrinsic test), CCR7 expression flow cytometry, FOXO1 protein analysis, AKT inhibition, TLR7 agonist and in vivo infection challenges","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-intrinsic KO chimeras, molecular pathway dissection (NR4A3-AKT-FOXO1-CCR7), multiple orthogonal methods","pmids":["27820700"],"is_preprint":false},{"year":2017,"finding":"TGFβR1 signaling has an indispensable cell-intrinsic role in the development of intestinal CD103+CD11b+ DCs; deletion of Tgfbr1 results in markedly fewer CD103+CD11b+ DCs and a reciprocal increase in CD103-CD11b+ DCs, reflecting defective differentiation from CD103-CD11b+ intermediaries rather than isolated loss of CD103 expression; absence of these DCs reduces generation of FoxP3+ regulatory T cells and numbers of endogenous Th17 cells.","method":"CD11c-Cre.Tgfbr1-fl/fl conditional KO mice, transcriptional profiling, in vitro and in vivo FoxP3+ Treg generation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO, transcriptional profiling, functional immune readouts in vitro and in vivo","pmids":["28931816"],"is_preprint":false},{"year":2017,"finding":"Nasal CD103+ DCs are indispensable for TLR3/TICAM-1-mediated IgA class switching and vaccine-specific IgA production; polyI:C is endocytosed into CD103+ DCs, activating TGF-β signaling and activation-induced cytidine deaminase, leading to T cell-dependent IgA production preferentially over IgG.","method":"Batf3-/- mice lacking CD103+ DCs, TLR3/TICAM-1 knockout mice, nasal immunization, IgA/IgG measurement, genomic recombination analysis","journal":"Mucosal immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple KO strains, mechanistic dissection of TGF-β/AID pathway, functional immunological readout","pmids":["28612840"],"is_preprint":false},{"year":2018,"finding":"CD103 mediates adhesion of intraepithelial lymphocytes to E-cadherin on dendritic cells (via membrane-bound TGF-β signaling from DCs), and endometrial DCs from postmenopausal women induce CD103 expression on allogeneic naïve CD8+ T cells through this membrane-bound TGF-β mechanism.","method":"Ex vivo DC-T cell co-culture from hysterectomy tissues, TGFβ signaling blockade, flow cytometry","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional co-culture assay with blocking experiments, single lab, limited mechanistic depth","pmids":["29455474"],"is_preprint":false},{"year":2019,"finding":"E-cadherin expression on tumor cells is required for CD103-mediated antitumor immunity in vivo; transplantation of E-cadherin-expressing B16F10 melanoma into CD103-/- mice abrogated the tumor growth delay seen with E-cadherin-expressing tumors, establishing that the antitumor response against E-cadherin+ tumors is both immune-mediated and CD103-dependent.","method":"E-cadherin-expressing B16F10 mouse melanoma model, Rag1-/- and CD103-/- mice, tumor growth and survival measurements","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO models (Rag1-/- and CD103-/-) with clear in vivo phenotype, causal mechanism established","pmids":["30674537"],"is_preprint":false},{"year":2019,"finding":"CD103+CD8+ tumor-infiltrating T cells produce and respond to TGFβ in a self-regulatory loop: differentiated CD103+ cancer-specific CTLs express the active form of TGFβ1 to self-maintain CD103 expression without relying on external TGFβ1-producing cells; CD103 on CTLs improves TCR antigen sensitivity enabling faster cancer recognition and rapid cytotoxicity.","method":"TCR-matched CD103+ and CD103- cancer-specific CTL pairs, in vitro functional assays, ex vivo immunophenotyping","journal":"Cancer immunology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — TCR-matched comparison with functional assays, single lab, multiple orthogonal measures","pmids":["31771983"],"is_preprint":false},{"year":2020,"finding":"CD103 (but not CD49a) supports adhesion of tissue-resident memory CD8 T cells in the lung; CD49a facilitates locomotion of virus-specific CD8 T cells both in vitro and in vivo, whereas CD103 and CD49a have distinct and separable functions in TRM biology post-influenza infection.","method":"Influenza virus infection mouse model, in vitro and in vivo motility assays, flow cytometry of CD103 and CD49a expression kinetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional motility assays in vitro and in vivo, single lab","pmids":["32439709"],"is_preprint":false},{"year":2020,"finding":"T cell factor 1 (Tcf1) directly binds to the Itgae locus (encoding CD103) and partly inhibits TGF-β-induced CD103 expression; T-cell-specific ablation of Tcf7 (encoding Tcf1) enhances CD103 protein expression in TRM cells and increases TRM cell numbers, demonstrating that Tcf1 suppresses CD103+ lung TRM cell development.","method":"Tcf7-conditional KO mice, ChIP (Tcf1 binding to Itgae locus), TGF-β signaling abrogation in vivo, flow cytometry","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct ChIP showing Tcf1 binding to Itgae locus, genetic KO with defined phenotype, TGF-β pathway epistasis","pmids":["32268106"],"is_preprint":false},{"year":2020,"finding":"The SKI proto-oncogene is recruited to the Itgae loci and directly suppresses CD103 transcription by regulating histone acetylation in a Smad4-dependent manner; ectopic SKI expression restricts CD103 expression in CD8+ T cells in vitro and in vivo, revealing a TGFβ-SKI-Smad4 pathway that controls resident CD103+CD8+ T cell generation.","method":"Ectopic SKI expression in vitro and in vivo, ChIP (SKI at Itgae locus), histone acetylation analysis, Smad4-dependent epistasis, viral infection model","journal":"Cellular & molecular immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct ChIP at Itgae locus, histone acetylation mechanism, in vitro and in vivo gain-of-function, single lab with multiple orthogonal methods","pmids":["32612153"],"is_preprint":false},{"year":2021,"finding":"CD103/E-cadherin ligation on γδ intraepithelial lymphocytes triggers extracellular release of granzymes A and B (but not perforin), facilitating TNF-mediated shedding of apoptotic enterocytes; CD103 knockout or blockade significantly reduced LPS-induced cell shedding in vivo.","method":"Intravital microscopy in GFP γδ T cell reporter mice, CD103-/- mice, anti-CD103 blocking antibody, granzyme ELISA from ex vivo-stimulated γδ IELs, ZO-1/caspase-3 immunostaining","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — intravital microscopy, genetic KO, antibody blockade, and ex vivo granzyme release assays all converging on same mechanism","pmids":["34861219"],"is_preprint":false},{"year":2021,"finding":"CD103 integrin availability for surface expression is constrained by the availability of integrin β7 (its heterodimerization partner); forced surface expression of CD103 does not significantly alter thymic development of conventional T cells but severely impairs generation of MHC-II-restricted TCR transgenic CD4 T cells, revealing CD103 involvement in CD4 T cell selection; the regulatory mechanism of CD103 expression is distinct between CD4 and CD8 T cells with Runx3 playing an important but non-essential role.","method":"Multiple genetically engineered mouse models including Runx3 KO, forced CD103 expression transgenics, TCR transgenic crosses, flow cytometry, thymic developmental analysis","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models, gain- and loss-of-function, defined developmental phenotype, multiple orthogonal approaches","pmids":["34129058"],"is_preprint":false},{"year":2021,"finding":"CD103 interacts with TCR α/β and CD3ζ (shown by immunoprecipitation); CD103 activation enhances phosphorylation of ZAP70 induced by TCR signaling, and blocking CD103 with a neutralizing antibody reduces T cell proliferation and cytokine (IFN-γ, TNF, IL-17) production in CD103+CD4+ T cells co-cultured with antigen-primed DCs.","method":"Co-immunoprecipitation (CD103 with TCR α/β and CD3ζ), ZAP70 phosphorylation assay, anti-CD103 neutralizing antibody blockade in DC-T cell co-culture","journal":"Frontiers in cellular and infection microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional validation by antibody blockade, single lab","pmids":["32974219"],"is_preprint":false},{"year":2021,"finding":"CD103-mediated E-cadherin contact between intraepithelial lymphocytes and intestinal epithelial cells is required for anti-tumor IEL activity; genetic deletion of CD103 decreased frequency of IEL-epithelial interactions and increased small intestinal tumor numbers; wild-type IEL-mediated reduction in tumor organoid viability was CD103-dependent and required cell-to-cell contact.","method":"CD103-/- mice in APCmin spontaneous tumor model, in vivo live-imaging, in vitro co-culture with tumor organoids, DPE-GFP reporter mice","journal":"Cellular and molecular gastroenterology and hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with in vivo tumor phenotype, intravital imaging, and in vitro co-culture mechanistic confirmation","pmids":["33515805"],"is_preprint":false},{"year":2022,"finding":"Intestinal CD103+ TRM cells, when fate-mapped, remain organ-confined during secondary infection, fail to re-expand, and do not autonomously maintain their population; CD103- TRM cells are the primary responders to secondary infection and give rise to new CD103+ cells de novo; CD103+ TRM become fully activated by inflammation alone (without antigen), whereas CD103- cells require both antigen and inflammation.","method":"Two novel mouse models: CD103+ fate-mapping (stable marking) and CD103- T cell depletion; Yersinia pseudotuberculosis secondary infection model; transcriptional profiling; in vitro and in vivo TCR reactivation assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — purpose-built fate-mapping and depletion mouse models, multiple functional and transcriptional readouts, orthogonal in vitro and in vivo experiments","pmids":["36332012"],"is_preprint":false},{"year":2023,"finding":"Retinoic acid signaling during T cell priming in mesenteric lymph nodes (MLN) licenses CD103+ TRM cell differentiation in the intestine independently of CCR9-mediated gut homing; T cells primed in the spleen are impaired in CD103+ TRM differentiation after intestinal entry, while MLN priming initiates a CD103+ TRM gene signature.","method":"Adoptive transfer comparing MLN-primed vs spleen-primed T cells, retinoic acid signaling blockade, CCR9-deficient T cells, gene expression profiling","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — adoptive transfer with defined priming sites, retinoic acid pathway blockade, CCR9 KO epistasis, gene signature analysis","pmids":["36809399"],"is_preprint":false},{"year":2023,"finding":"Itaconate (via its derivative 4-OI) inhibits the induction and effector functions of CD103+ TRM cells in vitro by blocking DNA demethylation of RUNX3 in CD8+ T cells; this reduces intrahepatic CD103+ TRM and ameliorates liver injury in murine PSC models.","method":"4-OI treatment in vitro and in vivo (PSC murine models), RUNX3 DNA methylation analysis, IRG1 KO mice, flow cytometry","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic RUNX3 DNA methylation finding with in vitro and in vivo validation, single lab","pmids":["37505225"],"is_preprint":false},{"year":2024,"finding":"CD103 pairs transiently with CD61 at synaptic microclusters of T cells; this CD61 colocalization with TCR further modulates downstream TCR signaling, improving antitumor cytotoxicity and promoting physiological tumor growth control.","method":"Co-localization imaging of CD61 and CD103 at immunological synapses, TCR signaling assays, in vivo tumor growth experiments","journal":"Nature immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — imaging of protein co-localization at synapse with downstream signaling and in vivo functional readout, single study","pmids":["38561495"],"is_preprint":false},{"year":2024,"finding":"Intraglandular anti-CD103 monoclonal antibody blockade in an experimental Sjögren's syndrome mouse model reduced CD103+ TRM cells, reduced glandular damage, and improved salivary flow, demonstrating a pathogenic role for CD103 in retaining/maintaining cytotoxic TRM cells in inflamed salivary glands.","method":"Experimental SS (ESS) mouse model, intraglandular anti-CD103 mAb injection, flow cytometry, histology, salivary flow measurement","journal":"Annals of the rheumatic diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo antibody blockade with functional phenotypic readout in disease model, single lab","pmids":["38777379"],"is_preprint":false}],"current_model":"ITGAE (CD103), the αE subunit of the αEβ7 integrin, binds E-cadherin on epithelial and tumor cells to mediate T cell and DC adhesion, retention, and epithelial infiltration; its expression on CD8+ T cells and regulatory T cells is driven transcriptionally by a TGF-β1/TCR co-stimulation axis through Smad2/3 and NFAT-1, positively regulated by Runx3 and retinoic acid signaling, and negatively regulated by Tcf1 and SKI (the latter via direct histone acetylation-dependent repression of the Itgae locus); CD103 co-associates with TCR/CD3ζ to amplify ZAP70 phosphorylation and T cell activation, pairs transiently with CD61 at the immunological synapse to enhance antitumor cytotoxicity, and on γδ intraepithelial lymphocytes triggers extracellular granzyme release upon E-cadherin ligation; CD103+ DCs form a developmental lineage dependent on Batf3, Irf8, Flt3L, and TGFβR1 and are specialized for antigen cross-presentation, CCR7-driven lymph node migration (regulated by NR4A3-AKT-FOXO1-CCR7 axis), and induction of gut-homing and tolerogenic T cell responses."},"narrative":{"mechanistic_narrative":"ITGAE (CD103) is the αE subunit of the αEβ7 integrin that mediates adhesion of T cells and dendritic cells to E-cadherin on epithelial and tumor cells, controlling lymphocyte retention and effector function in epithelial tissues [PMID:10978890, PMID:30674537]. On CD8+ T cells, CD103 promotes infiltration of epithelial compartments — CD103-deficient effector CD8 cells traffic to graft sites but fail to penetrate the epithelial layer [PMID:12370250] — and underlies the formation and tissue retention of CD103+ tissue-resident memory (TRM) cells, which arise from epithelium-infiltrating precursors under local IL-15 and TGF-β signaling [PMID:24162776, PMID:32439709]. Its induction on CD8 T cells is driven by co-engagement of the TCR and the TGF-β1 receptor, which cooperatively activate the ITGAE promoter and enhancer through Smad2/3 and NFAT-1 [PMID:24477908]; this axis is reinforced by Runx3 [PMID:16034110], retinoic-acid-dependent priming in mesenteric lymph nodes [PMID:36809399], and a CD103+ CTL-intrinsic autocrine TGF-β1 loop [PMID:31771983], and is negatively gated by Tcf1 and by the SKI proto-oncogene, which binds the Itgae locus and represses transcription via Smad4-dependent histone deacetylation [PMID:32268106, PMID:32612153]. Beyond adhesion, CD103 functions as a TCR co-receptor: it associates with TCRα/β and CD3ζ to amplify ZAP70 phosphorylation and cytokine production [PMID:32974219], pairs transiently with CD61 at synaptic microclusters to enhance antitumor cytotoxicity [PMID:38561495], improves TCR antigen sensitivity in cancer-specific CTLs [PMID:31771983], and on γδ intraepithelial lymphocytes triggers extracellular granzyme A/B release upon E-cadherin ligation to drive enterocyte shedding [PMID:34861219]. CD103 also marks a Batf3/Irf8/Flt3L-dependent dendritic-cell lineage specialized for antigen cross-presentation, CCR7-driven lymph-node migration, and induction of gut-homing, tolerogenic, and IgA-class-switched immune responses [PMID:20008528, PMID:20351058, PMID:21859845, PMID:25100743]. CD103-mediated retention of cytotoxic TRM cells is pathogenic in autoimmune tissue injury, as anti-CD103 blockade ameliorates experimental Sjögren's syndrome [PMID:38777379].","teleology":[{"year":2000,"claim":"Established the core ligand-receptor function: that αEβ7/CD103 binds E-cadherin to anchor intraepithelial CD8 T cells to epithelial surfaces, and that chemokine signaling tunes this adhesion.","evidence":"E-cadherin-Fc adhesion assays with CCL25/CCR9 stimulation and pertussis toxin inhibition","pmids":["10978890"],"confidence":"Medium","gaps":["Adhesion measured in vitro on Fc fusion, not tissue context","No structural basis of the αE/E-cadherin interaction defined"]},{"year":2002,"claim":"Answered whether CD103 adhesion has an in vivo functional consequence, showing it is specifically required for CD8 effector infiltration of epithelial layers rather than for trafficking to the tissue.","evidence":"Reciprocal adoptive transfer of WT vs CD103-/- CD8 T cells in an islet allograft model","pmids":["12370250"],"confidence":"High","gaps":["Does not address molecular signaling downstream of E-cadherin engagement","Limited to allograft setting"]},{"year":2005,"claim":"Identified the first transcription factor controlling CD103 expression, placing Runx3 upstream of αE induction during CD8 thymocyte development.","evidence":"Runx3 knockout and transgenic overexpression mouse models with thymic flow cytometry","pmids":["16034110"],"confidence":"High","gaps":["Direct binding of Runx3 to the Itgae locus not shown","Relationship to TGF-β signaling unresolved at this stage"]},{"year":2005,"claim":"Distinguished CD103's role on dendritic cells from its role on T cells, showing CD103+ DCs imprint gut-homing and tolerogenic T cell programs.","evidence":"CD103-/- mice in T cell transfer colitis, Treg adoptive transfer, DC-T co-culture","pmids":["16216886"],"confidence":"High","gaps":["Whether CD103 itself or a co-marker mediates DC function not separated","Molecular basis of CCR9 imprinting unaddressed"]},{"year":2010,"claim":"Defined the developmental program of the CD103+ DC lineage, establishing shared Batf3/Irf8 dependence linking nonlymphoid CD103+ DCs to lymphoid CD8α+ DCs.","evidence":"Batf3-/- and Irf8-/- mice across multiple tissues with viral challenge and expression profiling; extended by Flt3L/Id2/IRF8 and FLT3L/GM-CSF culture studies","pmids":["20351058","20008528","25100743"],"confidence":"High","gaps":["Does not address CD103's own functional contribution within these DCs","Subset heterogeneity (CD11b+ vs CD11b-) only partially resolved"]},{"year":2011,"claim":"Assigned a specialized effector function to CD103+ DCs — selective transport and cross-presentation of apoptotic-cell antigen requiring TLR3.","evidence":"Batf3-/- mice, in vivo apoptotic antigen transport assays, TLR3 ligation, CTL readout","pmids":["21859845"],"confidence":"High","gaps":["CD103 integrin function vs lineage marker role not dissected","Mechanism of selective apoptotic antigen capture unknown"]},{"year":2014,"claim":"Resolved the transcriptional logic of CD103 induction in CD8 T cells, mapping TGF-β1/TCR co-stimulation onto Smad2/3 and NFAT-1 acting at the human ITGAE promoter/enhancer.","evidence":"Human CTL clone system with promoter/enhancer mapping and transcription factor analysis","pmids":["24477908"],"confidence":"High","gaps":["Direct factor occupancy at endogenous locus in primary cells not shown","Integration with Runx3 not mapped"]},{"year":2013,"claim":"Connected CD103 to tissue-resident memory biology, showing CD103+CD8+ TRM arise from epithelium-infiltrating precursors via local IL-15 and TGF-β.","evidence":"Skin infection model, parabiosis, cytokine blockade, transcriptional profiling","pmids":["24162776"],"confidence":"High","gaps":["Whether CD103 is required for TRM formation vs a marker of it not separated here","Tissue specificity of the program incompletely defined"]},{"year":2009,"claim":"Extended CD103 function to the tumor microenvironment, linking TCR+TGF-β1-induced CD103 to E-cadherin engagement that retains CD8 T cells by recruiting CCR5 to the synapse.","evidence":"Adoptive transfer in NOD/SCID mice with immunological synapse and CCR5 recruitment analysis","pmids":["19638592"],"confidence":"Medium","gaps":["Single-lab mechanistic synapse analysis","Generality across tumor types not established"]},{"year":2016,"claim":"Dissected how CD103+ DCs migrate to lymph nodes, defining a cell-intrinsic NR4A3-AKT-FOXO1-CCR7 axis governing migration and mitochondrial homeostasis.","evidence":"Nr4a3-/- mixed bone marrow chimeras, FOXO1/CCR7 analysis, AKT inhibition, in vivo challenges","pmids":["27820700"],"confidence":"High","gaps":["Does not connect to CD103 integrin function per se","Whether axis operates in all CD103+ DC subsets unclear"]},{"year":2017,"claim":"Established TGFβR1 as a cell-intrinsic driver of intestinal CD103+CD11b+ DC differentiation, with downstream consequences for Treg and Th17 generation; complemented by TLR3/TICAM-1-dependent CD103+ DC control of IgA class switching.","evidence":"CD11c-Cre.Tgfbr1-fl/fl conditional KO with profiling and Treg assays; Batf3-/- and TLR3/TICAM-1 KO nasal immunization","pmids":["28931816","28612840"],"confidence":"High","gaps":["Role of CD103 protein vs the DC subset not isolated","Link between DC TGF-β signaling and αE expression mechanistic detail limited"]},{"year":2019,"claim":"Demonstrated CD103's ligand-dependent antitumor requirement and an autocrine maintenance loop, showing tumor E-cadherin and CTL-intrinsic active TGF-β1 sustain CD103-driven cytotoxicity and TCR sensitivity.","evidence":"E-cadherin+ B16F10 melanoma in Rag1-/- and CD103-/- mice; TCR-matched CD103+/CD103- CTL pairs","pmids":["30674537","31771983"],"confidence":"High","gaps":["Quantitative contribution of CD103 vs other adhesion molecules unresolved","Autocrine loop characterized in single lab"]},{"year":2020,"claim":"Separated CD103's adhesion role from motility (CD49a) in lung TRM and identified two transcriptional repressors of CD103 — Tcf1 and SKI — that directly bind the Itgae locus, with SKI repressing via Smad4-dependent histone acetylation.","evidence":"Influenza motility assays; Tcf7-cKO with ChIP; ectopic SKI with ChIP and histone acetylation analysis","pmids":["32439709","32268106","32612153"],"confidence":"High","gaps":["Interplay between activating (Smad2/3/NFAT/Runx3) and repressive (Tcf1/SKI) factors at the locus not integrated","Chromatin dynamics over T cell differentiation incompletely mapped"]},{"year":2021,"claim":"Defined CD103 as a TCR co-receptor and elaborated effector mechanisms across epithelial settings — TCR/CD3ζ association amplifying ZAP70, γδ IEL granzyme release upon E-cadherin ligation, and CD103-dependent IEL anti-tumor surveillance; also showed β7 availability and CD4 selection consequences.","evidence":"Co-IP and ZAP70 assays; intravital microscopy and granzyme ELISA in γδ IEL; APCmin tumor model with organoid co-culture; forced-expression and Runx3-KO mouse models","pmids":["32974219","34861219","33515805","34129058"],"confidence":"High","gaps":["Co-IP TCR association is single-lab without reciprocal/structural validation","How E-cadherin ligation transduces to granzyme release mechanistically unclear"]},{"year":2023,"claim":"Refined upstream control of CD103+ TRM by showing retinoic-acid priming in mesenteric lymph nodes licenses the program independent of gut homing, and that itaconate suppresses CD103 induction by blocking RUNX3 DNA demethylation.","evidence":"MLN- vs spleen-primed adoptive transfer with retinoic acid blockade and CCR9 KO; 4-OI treatment with RUNX3 methylation analysis and IRG1 KO","pmids":["36809399","37505225"],"confidence":"Medium","gaps":["Itaconate-RUNX3 link is single-lab","Metabolic regulation of the Itgae locus only partially defined"]},{"year":2024,"claim":"Identified CD61 as a transient synaptic partner of CD103 modulating TCR signaling and antitumor cytotoxicity, and validated CD103 as a therapeutic target for retaining pathogenic TRM in autoimmunity.","evidence":"Synaptic co-localization imaging with TCR signaling and tumor growth assays; intraglandular anti-CD103 mAb in experimental Sjögren's syndrome","pmids":["38561495","38777379"],"confidence":"Medium","gaps":["CD103-CD61 pairing characterized in single study without structural detail","Therapeutic blockade tested only in one autoimmune model"]},{"year":null,"claim":"How the activating (Smad2/3, NFAT-1, Runx3, retinoic acid) and repressive (Tcf1, SKI/Smad4) inputs are integrated at the Itgae locus to set CD103 levels in distinct T cell and DC contexts, and the structural basis of CD103's E-cadherin and TCR/CD3ζ interactions, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of αEβ7/E-cadherin binding in the corpus","Combined regulatory logic at the locus not reconstituted","TCR co-receptor mechanism lacks reciprocal/structural validation"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,1,17,22,25]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[24,29]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[24,29]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,4,8,22]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[0,17,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[24,29,6]}],"complexes":["αEβ7 integrin","TCR/CD3 complex (CD103-associated)"],"partners":["CDH1","ITGB7","CD3Z","TCR ALPHA/BETA","ITGB3 (CD61)"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P38570","full_name":"Integrin alpha-E","aliases":["HML-1 antigen","Integrin alpha-IEL","Mucosal lymphocyte 1 antigen"],"length_aa":1179,"mass_kda":130.2,"function":"Integrin ITGAE/ITGB7 (alpha-E/beta-7) is a receptor for E-cadherin. It mediates adhesion of intra-epithelial T-lymphocytes to epithelial cell monolayers","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/P38570/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ITGAE","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ITGAE","total_profiled":1310},"omim":[{"mim_id":"609240","title":"HISTONE H3-ASSOCIATED PROTEIN KINASE; HASPIN","url":"https://www.omim.org/entry/609240"},{"mim_id":"606065","title":"ATYPICAL CHEMOKINE RECEPTOR 4; ACKR4","url":"https://www.omim.org/entry/606065"},{"mim_id":"605984","title":"EMBRYONIC ECTODERM DEVELOPMENT; EED","url":"https://www.omim.org/entry/605984"},{"mim_id":"604874","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1","url":"https://www.omim.org/entry/604874"},{"mim_id":"604682","title":"INTEGRIN, ALPHA-E; ITGAE","url":"https://www.omim.org/entry/604682"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":6.1},{"tissue":"intestine","ntpm":5.5},{"tissue":"lung","ntpm":6.2}],"url":"https://www.proteinatlas.org/search/ITGAE"},"hgnc":{"alias_symbol":["CD103","HUMINAE"],"prev_symbol":[]},"alphafold":{"accession":"P38570","domains":[{"cath_id":"2.130.10.130","chopping":"22-142_403-677","consensus_level":"medium","plddt":87.0028,"start":22,"end":677},{"cath_id":"3.40.50.410","chopping":"202-387","consensus_level":"high","plddt":89.9552,"start":202,"end":387},{"cath_id":"2.60.40.1460","chopping":"680-818","consensus_level":"high","plddt":78.8378,"start":680,"end":818},{"cath_id":"2.60.40.1510","chopping":"834-964","consensus_level":"high","plddt":85.6619,"start":834,"end":964},{"cath_id":"2.60.40.1530","chopping":"971-1118","consensus_level":"high","plddt":80.063,"start":971,"end":1118}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P38570","model_url":"https://alphafold.ebi.ac.uk/files/AF-P38570-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P38570-F1-predicted_aligned_error_v6.png","plddt_mean":80.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ITGAE","jax_strain_url":"https://www.jax.org/strain/search?query=ITGAE"},"sequence":{"accession":"P38570","fasta_url":"https://rest.uniprot.org/uniprotkb/P38570.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P38570/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P38570"}},"corpus_meta":[{"pmid":"24162776","id":"PMC_24162776","title":"The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.","date":"2013","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24162776","citation_count":1109,"is_preprint":false},{"pmid":"27096321","id":"PMC_27096321","title":"Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27096321","citation_count":1002,"is_preprint":false},{"pmid":"27424807","id":"PMC_27424807","title":"Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.","date":"2016","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/27424807","citation_count":834,"is_preprint":false},{"pmid":"30006565","id":"PMC_30006565","title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30006565","citation_count":747,"is_preprint":false},{"pmid":"20351058","id":"PMC_20351058","title":"Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20351058","citation_count":610,"is_preprint":false},{"pmid":"20008528","id":"PMC_20008528","title":"The origin and development of nonlymphoid tissue CD103+ DCs.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20008528","citation_count":604,"is_preprint":false},{"pmid":"16216886","id":"PMC_16216886","title":"Essential role for CD103 in the T cell-mediated regulation of experimental colitis.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16216886","citation_count":392,"is_preprint":false},{"pmid":"29316433","id":"PMC_29316433","title":"TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/29316433","citation_count":327,"is_preprint":false},{"pmid":"32610077","id":"PMC_32610077","title":"Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32610077","citation_count":291,"is_preprint":false},{"pmid":"21859845","id":"PMC_21859845","title":"CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21859845","citation_count":253,"is_preprint":false},{"pmid":"20193025","id":"PMC_20193025","title":"Development and functional specialization of CD103+ dendritic cells.","date":"2010","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20193025","citation_count":215,"is_preprint":false},{"pmid":"30872264","id":"PMC_30872264","title":"A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.","date":"2019","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30872264","citation_count":201,"is_preprint":false},{"pmid":"30975145","id":"PMC_30975145","title":"CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.","date":"2019","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30975145","citation_count":189,"is_preprint":false},{"pmid":"25100743","id":"PMC_25100743","title":"Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25100743","citation_count":184,"is_preprint":false},{"pmid":"27267849","id":"PMC_27267849","title":"CD103 and Intratumoral Immune Response in Breast Cancer.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/27267849","citation_count":134,"is_preprint":false},{"pmid":"35367532","id":"PMC_35367532","title":"Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model.","date":"2022","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35367532","citation_count":131,"is_preprint":false},{"pmid":"10978890","id":"PMC_10978890","title":"T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines.","date":"2000","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10978890","citation_count":124,"is_preprint":false},{"pmid":"33827905","id":"PMC_33827905","title":"Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33827905","citation_count":121,"is_preprint":false},{"pmid":"31591568","id":"PMC_31591568","title":"CD103hi Treg cells constrain lung fibrosis induced by CD103lo tissue-resident pathogenic CD4 T cells.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31591568","citation_count":113,"is_preprint":false},{"pmid":"32439709","id":"PMC_32439709","title":"TRM integrins CD103 and CD49a differentially support adherence and motility after resolution of influenza virus infection.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32439709","citation_count":109,"is_preprint":false},{"pmid":"16034110","id":"PMC_16034110","title":"Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16034110","citation_count":108,"is_preprint":false},{"pmid":"30683885","id":"PMC_30683885","title":"FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30683885","citation_count":105,"is_preprint":false},{"pmid":"32273347","id":"PMC_32273347","title":"Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells.","date":"2020","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32273347","citation_count":93,"is_preprint":false},{"pmid":"28931816","id":"PMC_28931816","title":"TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28931816","citation_count":90,"is_preprint":false},{"pmid":"15368288","id":"PMC_15368288","title":"CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15368288","citation_count":81,"is_preprint":false},{"pmid":"19638592","id":"PMC_19638592","title":"Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19638592","citation_count":79,"is_preprint":false},{"pmid":"37081259","id":"PMC_37081259","title":"CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma.","date":"2023","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37081259","citation_count":78,"is_preprint":false},{"pmid":"12370250","id":"PMC_12370250","title":"CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells.","date":"2002","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12370250","citation_count":78,"is_preprint":false},{"pmid":"38445519","id":"PMC_38445519","title":"Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+CD103+CD8+ Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.","date":"2023","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/38445519","citation_count":69,"is_preprint":false},{"pmid":"24477908","id":"PMC_24477908","title":"Smad and NFAT pathways cooperate to induce CD103 expression in human CD8 T lymphocytes.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24477908","citation_count":67,"is_preprint":false},{"pmid":"32268106","id":"PMC_32268106","title":"T Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32268106","citation_count":66,"is_preprint":false},{"pmid":"33554350","id":"PMC_33554350","title":"The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/33554350","citation_count":65,"is_preprint":false},{"pmid":"24550510","id":"PMC_24550510","title":"Osteopontin expression by CD103- dendritic cells drives intestinal inflammation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24550510","citation_count":59,"is_preprint":false},{"pmid":"36332012","id":"PMC_36332012","title":"CD103 fate mapping reveals that intestinal CD103- tissue-resident memory T cells are the primary responders to secondary infection.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36332012","citation_count":58,"is_preprint":false},{"pmid":"32477365","id":"PMC_32477365","title":"KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32477365","citation_count":53,"is_preprint":false},{"pmid":"36809399","id":"PMC_36809399","title":"Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation.","date":"2023","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36809399","citation_count":52,"is_preprint":false},{"pmid":"17137867","id":"PMC_17137867","title":"Expression of CD103 identifies human regulatory T-cell subsets.","date":"2006","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17137867","citation_count":52,"is_preprint":false},{"pmid":"26376858","id":"PMC_26376858","title":"CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy.","date":"2015","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/26376858","citation_count":52,"is_preprint":false},{"pmid":"35753523","id":"PMC_35753523","title":"NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis.","date":"2022","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35753523","citation_count":49,"is_preprint":false},{"pmid":"30674537","id":"PMC_30674537","title":"Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30674537","citation_count":49,"is_preprint":false},{"pmid":"28438184","id":"PMC_28438184","title":"Microbiota-activated CD103+ DCs stemming from microbiota adaptation specifically drive γδT17 proliferation and activation.","date":"2017","source":"Microbiome","url":"https://pubmed.ncbi.nlm.nih.gov/28438184","citation_count":49,"is_preprint":false},{"pmid":"28700533","id":"PMC_28700533","title":"CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.","date":"2017","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28700533","citation_count":48,"is_preprint":false},{"pmid":"33922441","id":"PMC_33922441","title":"TGF-β: Many Paths to CD103+ CD8 T Cell Residency.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33922441","citation_count":45,"is_preprint":false},{"pmid":"30918941","id":"PMC_30918941","title":"Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.","date":"2019","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30918941","citation_count":45,"is_preprint":false},{"pmid":"23691170","id":"PMC_23691170","title":"Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responses.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23691170","citation_count":44,"is_preprint":false},{"pmid":"31771983","id":"PMC_31771983","title":"Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.","date":"2019","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31771983","citation_count":43,"is_preprint":false},{"pmid":"30361882","id":"PMC_30361882","title":"Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.","date":"2018","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/30361882","citation_count":42,"is_preprint":false},{"pmid":"29455474","id":"PMC_29455474","title":"Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract.","date":"2018","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/29455474","citation_count":41,"is_preprint":false},{"pmid":"34861219","id":"PMC_34861219","title":"γδ Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/34861219","citation_count":40,"is_preprint":false},{"pmid":"36332011","id":"PMC_36332011","title":"Secondary infections rejuvenate the intestinal CD103+ tissue-resident memory T cell pool.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36332011","citation_count":40,"is_preprint":false},{"pmid":"34505280","id":"PMC_34505280","title":"Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs.","date":"2021","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34505280","citation_count":40,"is_preprint":false},{"pmid":"33268774","id":"PMC_33268774","title":"CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33268774","citation_count":39,"is_preprint":false},{"pmid":"28941625","id":"PMC_28941625","title":"A Yin and Yang in Epithelial Immunology: The Roles of the αE(CD103)β7 Integrin in T Cells.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28941625","citation_count":38,"is_preprint":false},{"pmid":"32527931","id":"PMC_32527931","title":"CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma.","date":"2020","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32527931","citation_count":37,"is_preprint":false},{"pmid":"37658605","id":"PMC_37658605","title":"Intratumoral CD103+ CD8+ T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma.","date":"2023","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37658605","citation_count":36,"is_preprint":false},{"pmid":"18822329","id":"PMC_18822329","title":"Alloantigen-induced regulatory CD8+CD103+ T cells.","date":"2008","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18822329","citation_count":36,"is_preprint":false},{"pmid":"33548061","id":"PMC_33548061","title":"Implication of CD69+ CD103+ tissue-resident-like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma.","date":"2021","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/33548061","citation_count":36,"is_preprint":false},{"pmid":"25712214","id":"PMC_25712214","title":"Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25712214","citation_count":36,"is_preprint":false},{"pmid":"25681437","id":"PMC_25681437","title":"Pulmonary CD103 expression regulates airway inflammation in asthma.","date":"2015","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25681437","citation_count":35,"is_preprint":false},{"pmid":"28612840","id":"PMC_28612840","title":"Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production.","date":"2017","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28612840","citation_count":35,"is_preprint":false},{"pmid":"19289595","id":"PMC_19289595","title":"Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.","date":"2009","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19289595","citation_count":34,"is_preprint":false},{"pmid":"29515025","id":"PMC_29515025","title":"Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29515025","citation_count":32,"is_preprint":false},{"pmid":"26203637","id":"PMC_26203637","title":"Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity.","date":"2015","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/26203637","citation_count":32,"is_preprint":false},{"pmid":"35165401","id":"PMC_35165401","title":"CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer.","date":"2022","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35165401","citation_count":31,"is_preprint":false},{"pmid":"27820700","id":"PMC_27820700","title":"The transcription factor NR4A3 controls CD103+ dendritic cell migration.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27820700","citation_count":31,"is_preprint":false},{"pmid":"33654213","id":"PMC_33654213","title":"Circulating CD103+ γδ and CD8+ T cells are clonally shared with tissue-resident intraepithelial lymphocytes in celiac disease.","date":"2021","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33654213","citation_count":30,"is_preprint":false},{"pmid":"29288569","id":"PMC_29288569","title":"Sex-based differences in CD103+ dendritic cells promote female-predominant Th2 cytokine production during allergic asthma.","date":"2018","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29288569","citation_count":29,"is_preprint":false},{"pmid":"33515805","id":"PMC_33515805","title":"Intraepithelial Lymphocytes Suppress Intestinal Tumor Growth by Cell-to-Cell Contact via CD103/E-Cadherin Signal.","date":"2021","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33515805","citation_count":28,"is_preprint":false},{"pmid":"34944831","id":"PMC_34944831","title":"Integrin αE(CD103)β7 in Epithelial Cancer.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34944831","citation_count":26,"is_preprint":false},{"pmid":"36792124","id":"PMC_36792124","title":"CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36792124","citation_count":26,"is_preprint":false},{"pmid":"30590794","id":"PMC_30590794","title":"Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation.","date":"2019","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/30590794","citation_count":24,"is_preprint":false},{"pmid":"39491204","id":"PMC_39491204","title":"Tertiary lymphoid structure-associated B cells enhance CXCL13+CD103+CD8+Trm cell response to PD-1 blockade in gastric cancer.","date":"2023","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/39491204","citation_count":23,"is_preprint":false},{"pmid":"33312758","id":"PMC_33312758","title":"Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients.","date":"2020","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/33312758","citation_count":22,"is_preprint":false},{"pmid":"35794399","id":"PMC_35794399","title":"TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism.","date":"2022","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/35794399","citation_count":21,"is_preprint":false},{"pmid":"31921114","id":"PMC_31921114","title":"Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c+ Conventional Dendritic Cell Subsets Mediated by CD103 and CD205.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31921114","citation_count":21,"is_preprint":false},{"pmid":"38777379","id":"PMC_38777379","title":"CD8+ tissue-resident memory T cells are expanded in primary Sjögren's disease and can be therapeutically targeted by CD103 blockade.","date":"2024","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38777379","citation_count":20,"is_preprint":false},{"pmid":"31712385","id":"PMC_31712385","title":"Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31712385","citation_count":20,"is_preprint":false},{"pmid":"37097449","id":"PMC_37097449","title":"Depleting CD103+ resident memory T cells in vivo reveals immunostimulatory functions in oral mucosa.","date":"2023","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37097449","citation_count":19,"is_preprint":false},{"pmid":"34767045","id":"PMC_34767045","title":"Distribution, phenotype, functional and clinical relevance of CD8+CD103+ tissue-resident memory T cells in human gastric cancer.","date":"2021","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/34767045","citation_count":19,"is_preprint":false},{"pmid":"27191829","id":"PMC_27191829","title":"Batf3-dependent CD103(+) dendritic cell accumulation is dispensable for mucosal and systemic antifungal host defense.","date":"2016","source":"Virulence","url":"https://pubmed.ncbi.nlm.nih.gov/27191829","citation_count":18,"is_preprint":false},{"pmid":"38150880","id":"PMC_38150880","title":"PD-1 and TIGIT coexpressing CD8 + CD103 + tissue-resident memory cells in endometrial cancer as potential targets for immunotherapy.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38150880","citation_count":18,"is_preprint":false},{"pmid":"34658046","id":"PMC_34658046","title":"CD103 integrin identifies a high IL-10-producing FoxP3+ regulatory T-cell population suppressing allergic airway inflammation.","date":"2021","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/34658046","citation_count":18,"is_preprint":false},{"pmid":"31947933","id":"PMC_31947933","title":"STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31947933","citation_count":18,"is_preprint":false},{"pmid":"37505225","id":"PMC_37505225","title":"Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis.","date":"2023","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/37505225","citation_count":17,"is_preprint":false},{"pmid":"27328704","id":"PMC_27328704","title":"Distinct recirculation potential of CD69+CD103- and CD103+ thymic memory CD8+ T cells.","date":"2016","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27328704","citation_count":17,"is_preprint":false},{"pmid":"29922298","id":"PMC_29922298","title":"T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103+ Memory Status of CD8 T Cells in the Brain.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29922298","citation_count":17,"is_preprint":false},{"pmid":"32471032","id":"PMC_32471032","title":"Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32471032","citation_count":16,"is_preprint":false},{"pmid":"36384110","id":"PMC_36384110","title":"Agr2-associated ER stress promotes adherent-invasive E. coli dysbiosis and triggers CD103+ dendritic cell IL-23-dependent ileocolitis.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36384110","citation_count":15,"is_preprint":false},{"pmid":"25527788","id":"PMC_25527788","title":"IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25527788","citation_count":15,"is_preprint":false},{"pmid":"27481246","id":"PMC_27481246","title":"Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis.","date":"2016","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27481246","citation_count":15,"is_preprint":false},{"pmid":"30288359","id":"PMC_30288359","title":"Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma.","date":"2018","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/30288359","citation_count":15,"is_preprint":false},{"pmid":"38561495","id":"PMC_38561495","title":"Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38561495","citation_count":14,"is_preprint":false},{"pmid":"25241337","id":"PMC_25241337","title":"Essential role for CD103+ cells in the pathogenesis of spondyloarthritides.","date":"2014","source":"Joint bone spine","url":"https://pubmed.ncbi.nlm.nih.gov/25241337","citation_count":14,"is_preprint":false},{"pmid":"33845077","id":"PMC_33845077","title":"PD-1 Expression Defines Epidermal CD8+CD103+ T Cells Preferentially Producing IL-17A and Using Skewed TCR Repertoire in Psoriasis.","date":"2021","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/33845077","citation_count":14,"is_preprint":false},{"pmid":"32612153","id":"PMC_32612153","title":"The SKI proto-oncogene restrains the resident CD103+CD8+ T cell response in viral clearance.","date":"2020","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32612153","citation_count":14,"is_preprint":false},{"pmid":"34129058","id":"PMC_34129058","title":"The molecular basis and cellular effects of distinct CD103 expression on CD4 and CD8 T cells.","date":"2021","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/34129058","citation_count":14,"is_preprint":false},{"pmid":"32974219","id":"PMC_32974219","title":"CD103 Promotes the Pro-inflammatory Response of Gastric Resident CD4+ T Cell in Helicobacter pylori-Positive Gastritis.","date":"2020","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32974219","citation_count":14,"is_preprint":false},{"pmid":"37874322","id":"PMC_37874322","title":"Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease.","date":"2024","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/37874322","citation_count":13,"is_preprint":false},{"pmid":"37006318","id":"PMC_37006318","title":"IgA2 immune complexes selectively promote inflammation by human CD103+ dendritic cells.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37006318","citation_count":13,"is_preprint":false},{"pmid":"32209473","id":"PMC_32209473","title":"CD137 Signaling Regulates Acute Colitis via RALDH2-Expressing CD11b-CD103+ DCs.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32209473","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52181,"output_tokens":7834,"usd":0.137026,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17476,"output_tokens":5407,"usd":0.111278,"stage2_stop_reason":"end_turn"},"total_usd":0.248304,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"The αE(CD103)β7 integrin binds E-cadherin on epithelial cells, mediating T cell adhesion to epithelial surfaces. CCL25 (via CCR9) induces transient, dose-dependent and pertussis toxin-sensitive CD103-mediated adhesion of CD8+ intraepithelial lymphocytes to E-cadherin.\",\n      \"method\": \"Adhesion assay using murine E-cadherin-Fc fusion protein; pertussis toxin inhibition\",\n      \"journal\": \"Current opinion in cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional adhesion assay with pharmacological inhibition, single lab\",\n      \"pmids\": [\"10978890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CD103 expression on CD8+ T cells is required for intragraft migration into epithelial compartments and destruction of pancreatic islet allografts; CD103-/- CD8 cells trafficked normally to the graft site but failed to infiltrate the islet itself, demonstrating CD103's role in promoting CD8 effector infiltration of epithelial layers.\",\n      \"method\": \"Genetic knockout (CD103-/- mice), adoptive transfer of wild-type vs CD103-/- CD8 T cells, in vivo islet allograft transplantation model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal transfer experiments in KO and WT mice with clear phenotypic readout, well-controlled epistasis\",\n      \"pmids\": [\"12370250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCR9 signaling via its ligand CCL25 promotes induction of CD103 on CD8+ T cells upon entry into the small intestinal epithelium; CCR9-/- CD8 T cells showed significant delay in CD103 induction at this site.\",\n      \"method\": \"CCR9-/- mouse model, adoptive transfer, flow cytometry of intestinal intraepithelial lymphocytes\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined cellular phenotype, single lab\",\n      \"pmids\": [\"15368288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The transcription factor Runx3 is necessary for CD103 (integrin αE) induction during development of CD8 single-positive thymocytes; Runx3 deletion reduces CD103 expression, and Runx3 overexpression upregulates CD103 on CD8 SP T cells and a subpopulation of CD4 SP T cells.\",\n      \"method\": \"Runx3 knockout and transgenic overexpression mouse models, flow cytometry of thymic T cell subsets\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — both loss-of-function and gain-of-function genetic experiments with clear phenotypic readout, replicated across multiple mouse models in single study\",\n      \"pmids\": [\"16034110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD103 expression on dendritic cells (not T cells) is required for T regulatory cell-mediated control of colitis; CD103+ DCs (but not CD103- DCs) promote expression of gut-homing receptor CCR9 on T cells, while CD103- DCs promote IFN-γ-producing T cell differentiation.\",\n      \"method\": \"CD103-/- mice, T cell transfer colitis model, adoptive transfer of CD4+CD25+ Tregs, in vitro DC-T cell co-culture assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined functional readout, in vivo and in vitro orthogonal approaches, reciprocal transfer experiments\",\n      \"pmids\": [\"16216886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD103+ DCs in nonlymphoid tissues are exclusively derived from pre-DCs under control of Flt3 ligand, Id2, and IRF8, sharing the same precursor and differentiation program as lymphoid organ CD8+ DCs; in contrast, lamina propria CD103+CD11b+ DCs develop independently of Id2 and IRF8.\",\n      \"method\": \"Flt3-/-, Id2-/-, and IRF8-/- mouse models, bone marrow reconstitution, flow cytometry of DC subsets across tissues\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic KO models with defined developmental phenotypes across tissues\",\n      \"pmids\": [\"20008528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD103 expression on tumor-infiltrating CD8+ T cells is triggered by co-engagement of TCR and TGF-β1 receptor in the tumor microenvironment; once induced, αEβ7 integrin interaction with E-cadherin on tumor cells recruits CCR5 to the immunological synapse, inhibiting T cell sensitivity to CCL5 chemotactic gradient and promoting T cell retention at the tumor site.\",\n      \"method\": \"Adoptive transfer in NOD/SCID mice, in vivo TCR + TGF-β1 co-stimulation, immunological synapse analysis, CCR5 recruitment assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo adoptive transfer plus mechanistic synapse analysis, single lab, multiple methods\",\n      \"pmids\": [\"19638592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The transcription factor Batf3 is required for development of CD103+CD11b- DCs in lung, intestine, mesenteric lymph nodes, dermis, and skin-draining lymph nodes; Batf3-/- mice lack these cells and show reduced CD8 T cell priming after pulmonary viral infection, establishing a developmental relationship between lymphoid organ CD8α+ DCs and nonlymphoid CD103+ DCs via shared dependence on Batf3 and Irf8.\",\n      \"method\": \"Batf3-/- and Irf8-/- mouse models, flow cytometry across tissues, viral infection challenge, gene expression profiling\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple KO models, multiple tissues examined, functional immune readout, orthogonal gene expression data\",\n      \"pmids\": [\"20351058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CD103+ pulmonary DCs selectively acquire and transport apoptotic cell-associated antigen to draining lymph nodes and cross-present it to CD8 T cells; this selective role requires TLR3 expression on CD103+ DCs, and TLR3 ligation enhances CTL responses to apoptotic cell-associated antigen.\",\n      \"method\": \"Batf3-/- mice lacking CD103+ DCs, in vivo apoptotic cell transport assays, TLR3 ligation experiments, CTL response measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO confirmation, functional antigen transport and cross-presentation assays, TLR3 mechanistic link\",\n      \"pmids\": [\"21859845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD103+CD8+ tissue-resident memory T cells in skin develop from KLRG1- epithelium-infiltrating precursor cells; their formation requires a combination of epithelial entry plus local IL-15 and TGF-β signaling, and these cells acquire a unique transcriptional profile distinct from circulating memory cells.\",\n      \"method\": \"Mouse skin infection model, parabiosis, IL-15 and TGF-β blocking experiments, transcriptional profiling, flow cytometry\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — parabiosis, cytokine blocking, transcriptional profiling, multiple orthogonal methods in single study\",\n      \"pmids\": [\"24162776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The transcription factors Smad2/3 and NFAT-1 are critical regulators of CD103 induction in CD8 T cells; TGF-β1 and TCR co-engagement cooperatively drive CD103 (ITGAE gene) expression through promoter and enhancer elements of the human ITGAE gene.\",\n      \"method\": \"Human CTL clone system, Smad2/3 and NFAT-1 transcription factor analysis, ITGAE promoter/enhancer mapping, TGF-β1 and TCR stimulation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter/enhancer mapping with transcription factor identification, in vitro mechanistic dissection, single lab with multiple methods\",\n      \"pmids\": [\"24477908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CD103+ DC development in vitro requires prolonged culture with both FLT3L and GM-CSF acting on DC precursors and differentiating CD103+ DCs; these cells develop in a Batf3- and Irf8-dependent fashion, cross-present cell-associated antigens, respond to TLR3 stimulation, and upregulate CCR7 upon maturation enabling lymph node migration.\",\n      \"method\": \"Bone marrow culture differentiation, Batf3-/- and Irf8-/- genetic validation, antigen cross-presentation assays, TLR3 stimulation, CCR7 expression and migration assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic validation in KO mice plus multiple functional assays in single study\",\n      \"pmids\": [\"25100743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CD103-/- mice develop exacerbated lung inflammation with increased eosinophilic infiltration and defective resolution phase in asthma models, demonstrating CD103 plays a role in controlling airway inflammation severity.\",\n      \"method\": \"CD103-/- mice in ovalbumin and house dust mite asthma models, bronchoalveolar lavage analysis, histology, flow cytometry\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined phenotypic readout in two independent mouse models, single lab\",\n      \"pmids\": [\"25681437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The transcription factor NR4A3 is cell-intrinsically required for CD103+ DC migration to lymph nodes by regulating surface CCR7 expression on CD103+ DCs (but not T cells); NR4A3 maintains FOXO1 protein levels via an AKT-dependent mechanism, which in turn drives CCR7 expression; NR4A3 is also required for homeostatic mitochondrial function in CD103+ DCs.\",\n      \"method\": \"Nr4a3-/- mice, mixed bone marrow chimeras (cell-intrinsic test), CCR7 expression flow cytometry, FOXO1 protein analysis, AKT inhibition, TLR7 agonist and in vivo infection challenges\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-intrinsic KO chimeras, molecular pathway dissection (NR4A3-AKT-FOXO1-CCR7), multiple orthogonal methods\",\n      \"pmids\": [\"27820700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TGFβR1 signaling has an indispensable cell-intrinsic role in the development of intestinal CD103+CD11b+ DCs; deletion of Tgfbr1 results in markedly fewer CD103+CD11b+ DCs and a reciprocal increase in CD103-CD11b+ DCs, reflecting defective differentiation from CD103-CD11b+ intermediaries rather than isolated loss of CD103 expression; absence of these DCs reduces generation of FoxP3+ regulatory T cells and numbers of endogenous Th17 cells.\",\n      \"method\": \"CD11c-Cre.Tgfbr1-fl/fl conditional KO mice, transcriptional profiling, in vitro and in vivo FoxP3+ Treg generation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO, transcriptional profiling, functional immune readouts in vitro and in vivo\",\n      \"pmids\": [\"28931816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nasal CD103+ DCs are indispensable for TLR3/TICAM-1-mediated IgA class switching and vaccine-specific IgA production; polyI:C is endocytosed into CD103+ DCs, activating TGF-β signaling and activation-induced cytidine deaminase, leading to T cell-dependent IgA production preferentially over IgG.\",\n      \"method\": \"Batf3-/- mice lacking CD103+ DCs, TLR3/TICAM-1 knockout mice, nasal immunization, IgA/IgG measurement, genomic recombination analysis\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple KO strains, mechanistic dissection of TGF-β/AID pathway, functional immunological readout\",\n      \"pmids\": [\"28612840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CD103 mediates adhesion of intraepithelial lymphocytes to E-cadherin on dendritic cells (via membrane-bound TGF-β signaling from DCs), and endometrial DCs from postmenopausal women induce CD103 expression on allogeneic naïve CD8+ T cells through this membrane-bound TGF-β mechanism.\",\n      \"method\": \"Ex vivo DC-T cell co-culture from hysterectomy tissues, TGFβ signaling blockade, flow cytometry\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional co-culture assay with blocking experiments, single lab, limited mechanistic depth\",\n      \"pmids\": [\"29455474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"E-cadherin expression on tumor cells is required for CD103-mediated antitumor immunity in vivo; transplantation of E-cadherin-expressing B16F10 melanoma into CD103-/- mice abrogated the tumor growth delay seen with E-cadherin-expressing tumors, establishing that the antitumor response against E-cadherin+ tumors is both immune-mediated and CD103-dependent.\",\n      \"method\": \"E-cadherin-expressing B16F10 mouse melanoma model, Rag1-/- and CD103-/- mice, tumor growth and survival measurements\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO models (Rag1-/- and CD103-/-) with clear in vivo phenotype, causal mechanism established\",\n      \"pmids\": [\"30674537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CD103+CD8+ tumor-infiltrating T cells produce and respond to TGFβ in a self-regulatory loop: differentiated CD103+ cancer-specific CTLs express the active form of TGFβ1 to self-maintain CD103 expression without relying on external TGFβ1-producing cells; CD103 on CTLs improves TCR antigen sensitivity enabling faster cancer recognition and rapid cytotoxicity.\",\n      \"method\": \"TCR-matched CD103+ and CD103- cancer-specific CTL pairs, in vitro functional assays, ex vivo immunophenotyping\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — TCR-matched comparison with functional assays, single lab, multiple orthogonal measures\",\n      \"pmids\": [\"31771983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD103 (but not CD49a) supports adhesion of tissue-resident memory CD8 T cells in the lung; CD49a facilitates locomotion of virus-specific CD8 T cells both in vitro and in vivo, whereas CD103 and CD49a have distinct and separable functions in TRM biology post-influenza infection.\",\n      \"method\": \"Influenza virus infection mouse model, in vitro and in vivo motility assays, flow cytometry of CD103 and CD49a expression kinetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional motility assays in vitro and in vivo, single lab\",\n      \"pmids\": [\"32439709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"T cell factor 1 (Tcf1) directly binds to the Itgae locus (encoding CD103) and partly inhibits TGF-β-induced CD103 expression; T-cell-specific ablation of Tcf7 (encoding Tcf1) enhances CD103 protein expression in TRM cells and increases TRM cell numbers, demonstrating that Tcf1 suppresses CD103+ lung TRM cell development.\",\n      \"method\": \"Tcf7-conditional KO mice, ChIP (Tcf1 binding to Itgae locus), TGF-β signaling abrogation in vivo, flow cytometry\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct ChIP showing Tcf1 binding to Itgae locus, genetic KO with defined phenotype, TGF-β pathway epistasis\",\n      \"pmids\": [\"32268106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The SKI proto-oncogene is recruited to the Itgae loci and directly suppresses CD103 transcription by regulating histone acetylation in a Smad4-dependent manner; ectopic SKI expression restricts CD103 expression in CD8+ T cells in vitro and in vivo, revealing a TGFβ-SKI-Smad4 pathway that controls resident CD103+CD8+ T cell generation.\",\n      \"method\": \"Ectopic SKI expression in vitro and in vivo, ChIP (SKI at Itgae locus), histone acetylation analysis, Smad4-dependent epistasis, viral infection model\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct ChIP at Itgae locus, histone acetylation mechanism, in vitro and in vivo gain-of-function, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32612153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD103/E-cadherin ligation on γδ intraepithelial lymphocytes triggers extracellular release of granzymes A and B (but not perforin), facilitating TNF-mediated shedding of apoptotic enterocytes; CD103 knockout or blockade significantly reduced LPS-induced cell shedding in vivo.\",\n      \"method\": \"Intravital microscopy in GFP γδ T cell reporter mice, CD103-/- mice, anti-CD103 blocking antibody, granzyme ELISA from ex vivo-stimulated γδ IELs, ZO-1/caspase-3 immunostaining\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — intravital microscopy, genetic KO, antibody blockade, and ex vivo granzyme release assays all converging on same mechanism\",\n      \"pmids\": [\"34861219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD103 integrin availability for surface expression is constrained by the availability of integrin β7 (its heterodimerization partner); forced surface expression of CD103 does not significantly alter thymic development of conventional T cells but severely impairs generation of MHC-II-restricted TCR transgenic CD4 T cells, revealing CD103 involvement in CD4 T cell selection; the regulatory mechanism of CD103 expression is distinct between CD4 and CD8 T cells with Runx3 playing an important but non-essential role.\",\n      \"method\": \"Multiple genetically engineered mouse models including Runx3 KO, forced CD103 expression transgenics, TCR transgenic crosses, flow cytometry, thymic developmental analysis\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models, gain- and loss-of-function, defined developmental phenotype, multiple orthogonal approaches\",\n      \"pmids\": [\"34129058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD103 interacts with TCR α/β and CD3ζ (shown by immunoprecipitation); CD103 activation enhances phosphorylation of ZAP70 induced by TCR signaling, and blocking CD103 with a neutralizing antibody reduces T cell proliferation and cytokine (IFN-γ, TNF, IL-17) production in CD103+CD4+ T cells co-cultured with antigen-primed DCs.\",\n      \"method\": \"Co-immunoprecipitation (CD103 with TCR α/β and CD3ζ), ZAP70 phosphorylation assay, anti-CD103 neutralizing antibody blockade in DC-T cell co-culture\",\n      \"journal\": \"Frontiers in cellular and infection microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional validation by antibody blockade, single lab\",\n      \"pmids\": [\"32974219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD103-mediated E-cadherin contact between intraepithelial lymphocytes and intestinal epithelial cells is required for anti-tumor IEL activity; genetic deletion of CD103 decreased frequency of IEL-epithelial interactions and increased small intestinal tumor numbers; wild-type IEL-mediated reduction in tumor organoid viability was CD103-dependent and required cell-to-cell contact.\",\n      \"method\": \"CD103-/- mice in APCmin spontaneous tumor model, in vivo live-imaging, in vitro co-culture with tumor organoids, DPE-GFP reporter mice\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with in vivo tumor phenotype, intravital imaging, and in vitro co-culture mechanistic confirmation\",\n      \"pmids\": [\"33515805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Intestinal CD103+ TRM cells, when fate-mapped, remain organ-confined during secondary infection, fail to re-expand, and do not autonomously maintain their population; CD103- TRM cells are the primary responders to secondary infection and give rise to new CD103+ cells de novo; CD103+ TRM become fully activated by inflammation alone (without antigen), whereas CD103- cells require both antigen and inflammation.\",\n      \"method\": \"Two novel mouse models: CD103+ fate-mapping (stable marking) and CD103- T cell depletion; Yersinia pseudotuberculosis secondary infection model; transcriptional profiling; in vitro and in vivo TCR reactivation assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — purpose-built fate-mapping and depletion mouse models, multiple functional and transcriptional readouts, orthogonal in vitro and in vivo experiments\",\n      \"pmids\": [\"36332012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Retinoic acid signaling during T cell priming in mesenteric lymph nodes (MLN) licenses CD103+ TRM cell differentiation in the intestine independently of CCR9-mediated gut homing; T cells primed in the spleen are impaired in CD103+ TRM differentiation after intestinal entry, while MLN priming initiates a CD103+ TRM gene signature.\",\n      \"method\": \"Adoptive transfer comparing MLN-primed vs spleen-primed T cells, retinoic acid signaling blockade, CCR9-deficient T cells, gene expression profiling\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — adoptive transfer with defined priming sites, retinoic acid pathway blockade, CCR9 KO epistasis, gene signature analysis\",\n      \"pmids\": [\"36809399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Itaconate (via its derivative 4-OI) inhibits the induction and effector functions of CD103+ TRM cells in vitro by blocking DNA demethylation of RUNX3 in CD8+ T cells; this reduces intrahepatic CD103+ TRM and ameliorates liver injury in murine PSC models.\",\n      \"method\": \"4-OI treatment in vitro and in vivo (PSC murine models), RUNX3 DNA methylation analysis, IRG1 KO mice, flow cytometry\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic RUNX3 DNA methylation finding with in vitro and in vivo validation, single lab\",\n      \"pmids\": [\"37505225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CD103 pairs transiently with CD61 at synaptic microclusters of T cells; this CD61 colocalization with TCR further modulates downstream TCR signaling, improving antitumor cytotoxicity and promoting physiological tumor growth control.\",\n      \"method\": \"Co-localization imaging of CD61 and CD103 at immunological synapses, TCR signaling assays, in vivo tumor growth experiments\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — imaging of protein co-localization at synapse with downstream signaling and in vivo functional readout, single study\",\n      \"pmids\": [\"38561495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Intraglandular anti-CD103 monoclonal antibody blockade in an experimental Sjögren's syndrome mouse model reduced CD103+ TRM cells, reduced glandular damage, and improved salivary flow, demonstrating a pathogenic role for CD103 in retaining/maintaining cytotoxic TRM cells in inflamed salivary glands.\",\n      \"method\": \"Experimental SS (ESS) mouse model, intraglandular anti-CD103 mAb injection, flow cytometry, histology, salivary flow measurement\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo antibody blockade with functional phenotypic readout in disease model, single lab\",\n      \"pmids\": [\"38777379\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ITGAE (CD103), the αE subunit of the αEβ7 integrin, binds E-cadherin on epithelial and tumor cells to mediate T cell and DC adhesion, retention, and epithelial infiltration; its expression on CD8+ T cells and regulatory T cells is driven transcriptionally by a TGF-β1/TCR co-stimulation axis through Smad2/3 and NFAT-1, positively regulated by Runx3 and retinoic acid signaling, and negatively regulated by Tcf1 and SKI (the latter via direct histone acetylation-dependent repression of the Itgae locus); CD103 co-associates with TCR/CD3ζ to amplify ZAP70 phosphorylation and T cell activation, pairs transiently with CD61 at the immunological synapse to enhance antitumor cytotoxicity, and on γδ intraepithelial lymphocytes triggers extracellular granzyme release upon E-cadherin ligation; CD103+ DCs form a developmental lineage dependent on Batf3, Irf8, Flt3L, and TGFβR1 and are specialized for antigen cross-presentation, CCR7-driven lymph node migration (regulated by NR4A3-AKT-FOXO1-CCR7 axis), and induction of gut-homing and tolerogenic T cell responses.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ITGAE (CD103) is the αE subunit of the αEβ7 integrin that mediates adhesion of T cells and dendritic cells to E-cadherin on epithelial and tumor cells, controlling lymphocyte retention and effector function in epithelial tissues [#0, #17]. On CD8+ T cells, CD103 promotes infiltration of epithelial compartments — CD103-deficient effector CD8 cells traffic to graft sites but fail to penetrate the epithelial layer [#1] — and underlies the formation and tissue retention of CD103+ tissue-resident memory (TRM) cells, which arise from epithelium-infiltrating precursors under local IL-15 and TGF-β signaling [#9, #19]. Its induction on CD8 T cells is driven by co-engagement of the TCR and the TGF-β1 receptor, which cooperatively activate the ITGAE promoter and enhancer through Smad2/3 and NFAT-1 [#10]; this axis is reinforced by Runx3 [#3], retinoic-acid-dependent priming in mesenteric lymph nodes [#27], and a CD103+ CTL-intrinsic autocrine TGF-β1 loop [#18], and is negatively gated by Tcf1 and by the SKI proto-oncogene, which binds the Itgae locus and represses transcription via Smad4-dependent histone deacetylation [#20, #21]. Beyond adhesion, CD103 functions as a TCR co-receptor: it associates with TCRα/β and CD3ζ to amplify ZAP70 phosphorylation and cytokine production [#24], pairs transiently with CD61 at synaptic microclusters to enhance antitumor cytotoxicity [#29], improves TCR antigen sensitivity in cancer-specific CTLs [#18], and on γδ intraepithelial lymphocytes triggers extracellular granzyme A/B release upon E-cadherin ligation to drive enterocyte shedding [#22]. CD103 also marks a Batf3/Irf8/Flt3L-dependent dendritic-cell lineage specialized for antigen cross-presentation, CCR7-driven lymph-node migration, and induction of gut-homing, tolerogenic, and IgA-class-switched immune responses [#5, #7, #8, #11]. CD103-mediated retention of cytotoxic TRM cells is pathogenic in autoimmune tissue injury, as anti-CD103 blockade ameliorates experimental Sjögren's syndrome [#30].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established the core ligand-receptor function: that αEβ7/CD103 binds E-cadherin to anchor intraepithelial CD8 T cells to epithelial surfaces, and that chemokine signaling tunes this adhesion.\",\n      \"evidence\": \"E-cadherin-Fc adhesion assays with CCL25/CCR9 stimulation and pertussis toxin inhibition\",\n      \"pmids\": [\"10978890\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Adhesion measured in vitro on Fc fusion, not tissue context\", \"No structural basis of the αE/E-cadherin interaction defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Answered whether CD103 adhesion has an in vivo functional consequence, showing it is specifically required for CD8 effector infiltration of epithelial layers rather than for trafficking to the tissue.\",\n      \"evidence\": \"Reciprocal adoptive transfer of WT vs CD103-/- CD8 T cells in an islet allograft model\",\n      \"pmids\": [\"12370250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address molecular signaling downstream of E-cadherin engagement\", \"Limited to allograft setting\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified the first transcription factor controlling CD103 expression, placing Runx3 upstream of αE induction during CD8 thymocyte development.\",\n      \"evidence\": \"Runx3 knockout and transgenic overexpression mouse models with thymic flow cytometry\",\n      \"pmids\": [\"16034110\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding of Runx3 to the Itgae locus not shown\", \"Relationship to TGF-β signaling unresolved at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Distinguished CD103's role on dendritic cells from its role on T cells, showing CD103+ DCs imprint gut-homing and tolerogenic T cell programs.\",\n      \"evidence\": \"CD103-/- mice in T cell transfer colitis, Treg adoptive transfer, DC-T co-culture\",\n      \"pmids\": [\"16216886\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD103 itself or a co-marker mediates DC function not separated\", \"Molecular basis of CCR9 imprinting unaddressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the developmental program of the CD103+ DC lineage, establishing shared Batf3/Irf8 dependence linking nonlymphoid CD103+ DCs to lymphoid CD8α+ DCs.\",\n      \"evidence\": \"Batf3-/- and Irf8-/- mice across multiple tissues with viral challenge and expression profiling; extended by Flt3L/Id2/IRF8 and FLT3L/GM-CSF culture studies\",\n      \"pmids\": [\"20351058\", \"20008528\", \"25100743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address CD103's own functional contribution within these DCs\", \"Subset heterogeneity (CD11b+ vs CD11b-) only partially resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Assigned a specialized effector function to CD103+ DCs — selective transport and cross-presentation of apoptotic-cell antigen requiring TLR3.\",\n      \"evidence\": \"Batf3-/- mice, in vivo apoptotic antigen transport assays, TLR3 ligation, CTL readout\",\n      \"pmids\": [\"21859845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CD103 integrin function vs lineage marker role not dissected\", \"Mechanism of selective apoptotic antigen capture unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved the transcriptional logic of CD103 induction in CD8 T cells, mapping TGF-β1/TCR co-stimulation onto Smad2/3 and NFAT-1 acting at the human ITGAE promoter/enhancer.\",\n      \"evidence\": \"Human CTL clone system with promoter/enhancer mapping and transcription factor analysis\",\n      \"pmids\": [\"24477908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct factor occupancy at endogenous locus in primary cells not shown\", \"Integration with Runx3 not mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected CD103 to tissue-resident memory biology, showing CD103+CD8+ TRM arise from epithelium-infiltrating precursors via local IL-15 and TGF-β.\",\n      \"evidence\": \"Skin infection model, parabiosis, cytokine blockade, transcriptional profiling\",\n      \"pmids\": [\"24162776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD103 is required for TRM formation vs a marker of it not separated here\", \"Tissue specificity of the program incompletely defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended CD103 function to the tumor microenvironment, linking TCR+TGF-β1-induced CD103 to E-cadherin engagement that retains CD8 T cells by recruiting CCR5 to the synapse.\",\n      \"evidence\": \"Adoptive transfer in NOD/SCID mice with immunological synapse and CCR5 recruitment analysis\",\n      \"pmids\": [\"19638592\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab mechanistic synapse analysis\", \"Generality across tumor types not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Dissected how CD103+ DCs migrate to lymph nodes, defining a cell-intrinsic NR4A3-AKT-FOXO1-CCR7 axis governing migration and mitochondrial homeostasis.\",\n      \"evidence\": \"Nr4a3-/- mixed bone marrow chimeras, FOXO1/CCR7 analysis, AKT inhibition, in vivo challenges\",\n      \"pmids\": [\"27820700\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not connect to CD103 integrin function per se\", \"Whether axis operates in all CD103+ DC subsets unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established TGFβR1 as a cell-intrinsic driver of intestinal CD103+CD11b+ DC differentiation, with downstream consequences for Treg and Th17 generation; complemented by TLR3/TICAM-1-dependent CD103+ DC control of IgA class switching.\",\n      \"evidence\": \"CD11c-Cre.Tgfbr1-fl/fl conditional KO with profiling and Treg assays; Batf3-/- and TLR3/TICAM-1 KO nasal immunization\",\n      \"pmids\": [\"28931816\", \"28612840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of CD103 protein vs the DC subset not isolated\", \"Link between DC TGF-β signaling and αE expression mechanistic detail limited\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated CD103's ligand-dependent antitumor requirement and an autocrine maintenance loop, showing tumor E-cadherin and CTL-intrinsic active TGF-β1 sustain CD103-driven cytotoxicity and TCR sensitivity.\",\n      \"evidence\": \"E-cadherin+ B16F10 melanoma in Rag1-/- and CD103-/- mice; TCR-matched CD103+/CD103- CTL pairs\",\n      \"pmids\": [\"30674537\", \"31771983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of CD103 vs other adhesion molecules unresolved\", \"Autocrine loop characterized in single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Separated CD103's adhesion role from motility (CD49a) in lung TRM and identified two transcriptional repressors of CD103 — Tcf1 and SKI — that directly bind the Itgae locus, with SKI repressing via Smad4-dependent histone acetylation.\",\n      \"evidence\": \"Influenza motility assays; Tcf7-cKO with ChIP; ectopic SKI with ChIP and histone acetylation analysis\",\n      \"pmids\": [\"32439709\", \"32268106\", \"32612153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between activating (Smad2/3/NFAT/Runx3) and repressive (Tcf1/SKI) factors at the locus not integrated\", \"Chromatin dynamics over T cell differentiation incompletely mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined CD103 as a TCR co-receptor and elaborated effector mechanisms across epithelial settings — TCR/CD3ζ association amplifying ZAP70, γδ IEL granzyme release upon E-cadherin ligation, and CD103-dependent IEL anti-tumor surveillance; also showed β7 availability and CD4 selection consequences.\",\n      \"evidence\": \"Co-IP and ZAP70 assays; intravital microscopy and granzyme ELISA in γδ IEL; APCmin tumor model with organoid co-culture; forced-expression and Runx3-KO mouse models\",\n      \"pmids\": [\"32974219\", \"34861219\", \"33515805\", \"34129058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-IP TCR association is single-lab without reciprocal/structural validation\", \"How E-cadherin ligation transduces to granzyme release mechanistically unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Refined upstream control of CD103+ TRM by showing retinoic-acid priming in mesenteric lymph nodes licenses the program independent of gut homing, and that itaconate suppresses CD103 induction by blocking RUNX3 DNA demethylation.\",\n      \"evidence\": \"MLN- vs spleen-primed adoptive transfer with retinoic acid blockade and CCR9 KO; 4-OI treatment with RUNX3 methylation analysis and IRG1 KO\",\n      \"pmids\": [\"36809399\", \"37505225\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Itaconate-RUNX3 link is single-lab\", \"Metabolic regulation of the Itgae locus only partially defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified CD61 as a transient synaptic partner of CD103 modulating TCR signaling and antitumor cytotoxicity, and validated CD103 as a therapeutic target for retaining pathogenic TRM in autoimmunity.\",\n      \"evidence\": \"Synaptic co-localization imaging with TCR signaling and tumor growth assays; intraglandular anti-CD103 mAb in experimental Sjögren's syndrome\",\n      \"pmids\": [\"38561495\", \"38777379\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CD103-CD61 pairing characterized in single study without structural detail\", \"Therapeutic blockade tested only in one autoimmune model\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the activating (Smad2/3, NFAT-1, Runx3, retinoic acid) and repressive (Tcf1, SKI/Smad4) inputs are integrated at the Itgae locus to set CD103 levels in distinct T cell and DC contexts, and the structural basis of CD103's E-cadherin and TCR/CD3ζ interactions, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of αEβ7/E-cadherin binding in the corpus\", \"Combined regulatory logic at the locus not reconstituted\", \"TCR co-receptor mechanism lacks reciprocal/structural validation\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 1, 17, 22, 25]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [24, 29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [24, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 4, 8, 22]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 17, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [24, 29, 6]}\n    ],\n    \"complexes\": [\"αEβ7 integrin\", \"TCR/CD3 complex (CD103-associated)\"],\n    \"partners\": [\"CDH1\", \"ITGB7\", \"CD3Z\", \"TCR alpha/beta\", \"ITGB3 (CD61)\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}